<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002004379</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001936258</issuerCik>
      <issuerName>NewAmsterdam Pharma Co N.V.</issuerName>
      <secFileNumber>001-41562</secFileNumber>
      <issuerAddress>
        <com:street1>GOOIMEER 2-35</com:street1>
        <com:city>NARRDEN</com:city>
        <com:stateOrCountry>P7</com:stateOrCountry>
        <com:zipCode>1411 DC</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>35 206 2971</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Kooij Louise Frederika</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Ordinary shares, nominal value EUR 0.12 per share</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Cooperatieve Rabobank U.A.</name>
        <address>
          <com:street1>Croeselaan 18</com:street1>
          <com:city>Utrecht</com:city>
          <com:stateOrCountry>P7</com:stateOrCountry>
          <com:zipCode>3521 CB</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>18073</noOfUnitsSold>
      <aggregateMarketValue>434655.65</aggregateMarketValue>
      <noOfUnitsOutstanding>112628458</noOfUnitsOutstanding>
      <approxSaleDate>09/03/2025</approxSaleDate>
      <securitiesExchangeName>Nasdaq Global Market</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Ordinary shares, nominal value EUR 0.12 per share</securitiesClassTitle>
      <acquiredDate>09/02/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Option Exercise</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>NewAmsterdam Pharma Company N.V.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>18073</amountOfSecuritiesAcquired>
      <paymentDate>09/02/2025</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Louise Kooij</name>
        <address>
          <com:street1>Gooimeer 2-35</com:street1>
          <com:city>Naarden</com:city>
          <com:stateOrCountry>P7</com:stateOrCountry>
          <com:zipCode>1411 DC</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Ordinary shares, nominal value EUR 0.12 per share</securitiesClassTitle>
      <saleDate>08/25/2025</saleDate>
      <amountOfSecuritiesSold>8269</amountOfSecuritiesSold>
      <grossProceeds>205547.82</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>09/03/2025</noticeDate>
      <signature>/s/ Louise Kooij</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
